Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2025
2025-04-23 10:45
Study highlights speed of biomarker integration on Psyros POC platform
2025-03-31 08:00
Prolight announces positive pre-clinical data
Regulatory
MAR
2025-03-26 08:00
Prolight receives notice of allowance for MicroFlex patent
2025-03-13 08:00
The Psyros™ Cartridge Pilot Manufacturing line achieves another milestone!
2025-02-28 09:50
Prolight Diagnostics publishes year-end report 2024
Regulatory
MAR
2025-02-19 08:00
Prolight receives second Notice of Intention to Grant from European Patent Office for Psyros™ technology
2025-02-18 08:00
Prolight receives Notice of Intention to Grant for core Psyros™ patent
2024
2024-12-17 11:00
Prolight Diagnostics publishes investor letter for December 2024
2024-12-09 08:00
Prolight strengthens IP portfolio by additional patent application
2024-12-03 13:41
EMERGERS VALUE PROLIGHT DIAGNOSTICS AT 730 MSEK (0,9- 1,0 SEK PER SHARE)
Next
